Titoli del Settore Sanitario
| # | Ultimi 7 Giorni | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| 5123 |  WOK WORK Medical Technology Group LTD - Class A Ordinary Shares | 1.09 USD | -18.66% | -28.76% | -42.33% | +2625.00% | 16.00 USD | ||
| 5139 |  GMAB Genmab A/S - American Depositary Shares | 37.00 USD | -2.17% | -0.51% | +6.63% | +17.50% | 0 USD | ||
| 5171 |  OCS Oculis Holding AG - Ordinary shares | 7.29 USD | -1.49% | -11.85% | -28.46% | -66.86% | 0 USD | ||
| 5173 |  AZN AstraZeneca PLC - American Depositary Shares | 165.40 USD | -0.76% | +3.81% | -1.72% | +94.91% | 0 USD | ||
| 5184 |  ANL Adlai Nortye Ltd - American Depositary Shares | 11.03 USD | -8.77% | -29.52% | -30.63% | +548.82% | 0 USD | ||
| 5244 |  GRFS Grifols, S.A. - American Depositary Shares | 7.64 USD | +1.33% | +1.73% | +4.09% | -20.08% | 0 USD | ||
| 5255 |  NVO Novo Nordisk A/S | 38.82 USD | -1.07% | -0.05% | -5.39% | -29.95% | 0 USD | ||
| 5470 |  CELG-RT Bristol-Myers Squibb Company Celegne Contingent Value Rights | 0.1195 USD | 0.00% | +20.71% | -6.20% | +295.70% | 0 USD | ||
| 6280 |  NOTV Inotiv, Inc. - Common Stock | 0.08 USD | 0.00% | -33.33% | -70.37% | -94.07% | 2.79 M USD | ||
| 6287 |  ADAP Adaptimmune Therapeutics plc - American Depositary Shares | 0.05 USD | 0.00% | 0.00% | -61.54% | -28.57% | 0 USD | ||
| 6415 |  RVMDW Revolution Medicines, Inc. - Warrant | 8.4000 USD | -13.98% | -9.19% | -17.38% | +2525.00% | 38.14 B USD | ||
| 6502 |  BTSGU BrightSpring Health Services, Inc. - Tangible Equity Unit | 186.0000 USD | -9.45% | -9.72% | +0.64% | +81.32% | 12.04 B USD | ||
| 6543 |  BIO-B Bio-Rad Laboratories, Inc. Class B Common Stock | 364.15 USD | 0.00% | -0.02% | -0.02% | +20.12% | 9.46 B USD | ||
| 6549 |  BRKRP Bruker Corporation - 6.375% Mandatory Convertible Preferred Stock, Series A | 405.85 USD | -2.82% | -3.38% | -10.34% | +26.96% | 8.50 B USD | ||
| 6649 |  NAMSW NewAmsterdam Pharma Company N.V. - Warrant | 8.8200 USD | 0.00% | -17.57% | -23.24% | -66.95% | 2.37 B USD | ||
| 6698 |  ALVOW Alvotech - Warrant | 0.4496 USD | 0.00% | -0.09% | +18.35% | -70.03% | 1.56 B USD | ||
| 6716 |  DRTSW Alpha Tau Medical Ltd. - Warrant | 2.6799 USD | -10.37% | -26.18% | -39.78% | +793.30% | 1.08 B USD | ||
| 6817 |  YDESW YD Bio Limited - Warrants | 0.5990 USD | -9.24% | +36.95% | +81.52% | -75.04% | 419.07 M USD | ||
| 6908 |  PRENW Prenetics Global Limited - Warrant | 0.0113 USD | 0.00% | +16.49% | -9.60% | -58.46% | 312.51 M USD | ||
| 7001 |  SABSW SAB Biotherapeutics, Inc. - Warrant | 0.0072 USD | 0.00% | -57.65% | -52.32% | -77.85% | 230.20 M USD |
Notizie Titoli del Settore Sanitario
Centene balza del 57% dopo il segnale di Fair Value di InvestingPro
L’analisi Fair Value di InvestingPro individua un guadagno del 67% su Certara
Il dirigente di Gilead vende azioni GILD per $468.660
Il presidente di Moderna Stephen Hoge vende azioni per $17 mln
La CEO di United Therapeutics vende titoli per 5,19 milioni di dollari
La COO di Progyny Melissa Cummings vende azioni per $52.612
Il presidente esecutivo di Natera Matthew Rabinowitz vende azioni per $20,1 mln
Gainers Titoli del Settore Sanitario
 NXGLW NexGel, Inc - Warrant | 0.0099 | +52.31% |
 CTSO Cytosorbents Corporation - Common Stock | 4.11 | +34.31% |
 ACTU Actuate Therapeutics, Inc. - Common stock | 0.61 | +22.00% |
 TCRT Alaunos Therapeutics, Inc. - Common Stock | 2.63 | +20.64% |
 REVBW Revelation Biosciences, Inc. - Warrant | 0.0075 | +17.19% |
 CDT CDT Equity Inc. - Common Stock | 0.24 | +14.29% |
 MRKR Marker Therapeutics, Inc. - Common Stock | 1.04 | +13.04% |
 CVKD Cadrenal Therapeutics, Inc. - Common Stock | 1.09 | +12.37% |
Losers Titoli del Settore Sanitario
 BEATW Heartbeam, Inc. - Warrant | 0.0031 | -65.56% |
 MDXH MDxHealth SA - American Depositary Shares | 0.21 | -65.00% |
 GUTS Fractyl Health, Inc. - Common Stock | 1.55 | -62.74% |
 REVB Revelation Biosciences, Inc. - Common Stock | 0.48 | -36.84% |
 CDIOW Cardio Diagnostics Holdings Inc. - Warrant | 0.0064 | -28.09% |
 MBRX Moleculin Biotech, Inc. - Common Stock | 0.28 | -24.32% |
 JAGX Jaguar Health, Inc. - Common Stock | 3.53 | -23.09% |
 SLXN Silexion Therapeutics Corp - Ordinary Shares | 0.15 | -21.05% |